163 filings
Page 6 of 9
6-K
AMYT
Amryt Pharma Plc
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
AMYT
Amryt Pharma Plc
2 Jun 21
Prospectus supplement
10:10am
424B3
AMYT
Amryt Pharma Plc
2 Jun 21
Prospectus supplement
10:09am
424B3
AMYT
Amryt Pharma Plc
2 Jun 21
Prospectus supplement
10:08am
6-K
AMYT
Amryt Pharma Plc
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
AMYT
Amryt Pharma Plc
5 May 21
Business combination disclosure
5:27pm
425
AMYT
Amryt Pharma Plc
5 May 21
Business combination disclosure
5:26pm
425
AMYT
Amryt Pharma Plc
5 May 21
Business combination disclosure
5:25pm
425
AMYT
Amryt Pharma Plc
5 May 21
Business combination disclosure
5:24pm
6-K
AMYT
Amryt Pharma Plc
5 May 21
Agreement and Plan of Merger
5:19pm
SC 13G
AMYT
Amryt Pharma Plc
5 May 21
Amryt Pharma / EdgePoint Investment ownership change
5:07pm
6-K
AMYT
Amryt Pharma Plc
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
AMYT
Amryt Pharma Plc
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
6-K
AMYT
Amryt Pharma Plc
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
424B3
AMYT
Amryt Pharma Plc
4 Mar 21
Prospectus supplement
8:38am
6-K
AMYT
Amryt Pharma Plc
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
SC 13G
Ubs Oconnor LLC
16 Feb 21
Amryt Pharma / UBS OCONNOR ownership change
10:32am
SC 13G/A
AMYT
Amryt Pharma Plc
12 Feb 21
Amryt Pharma / Stonepine Capital Management ownership change
4:37pm
SC 13G
Athyrium Opportunities III Acquisition 2 LP
12 Feb 21
Amryt Pharma / Athyrium Opportunities III Acquisition 2 ownership change
8:01am